Not checkedNot checked for notices yet.
Host cell cycle checkpoint as antiviral target for SARS-CoV-2 revealed by integrative transcriptome and proteome analyses
Liyan Sui, Letian Li, Yinghua Zhao and 7 more
Signal Transduction and Targeted Therapy · 2023
doi:10.1038/s41392-022-01296-1 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic, has posed severe threats to global public health, highlighting an urgent need to understand its pathogenesis and to develop antiviral therapies. Both DNA and RNA viruses can modulate cell cycle progression to maximize their replication. 1 However, the effects of SARS-CoV-2 on cell cycle progression remains largely unknown.
Abstract licence: CC BY-NC-ND
References5
5 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.